Network for Advancing Sex Chromosome Aneuploidy Research Readiness

The Network for Advancing Sex Chromosome Aneuploidy Research Readiness (NASCARR) is part of the [Rare Diseases Clinical Research Network](https://rarediseasesnetwork.org/) (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the [National Center for Advancing Translational Sciences](https://ncats.nih.gov/ "Learn more from NCATS. Opens in New Window.") (NCATS) through its Division of Rare Diseases Research Innovation (DRDRI). NASCARR is funded under grant number U54HD121580 as a collaboration between NCATS, the [Eunice Kennedy Shriver National Institute of Child Health and Human Development](https://www.nichd.nih.gov/ "Learn more from NICHD. Opens in New Window.") (NICHD), and the [National Human Genome Research Institute](https://www.genome.gov/ "Learn more from NHGRI. Opens in New Window.") (NHGRI). This website is hosted by the network's Data Management and Coordinating Center at Cincinnati Children's Hospital Medical Center, which is funded by NCATS and the [National Institute of Neurological Disorders and Stroke](https://www.ninds.nih.gov/) (NINDS) under grant number TR002818. The content of this website is solely the responsibility of the NASCARR administrative coordinating center at Children's Hospital Colorado Anschutz Medical Campus and does not necessarily represent the official views of the NIH NASCARR's mission is to unite researchers, clinicians, patients, families, and advocacy organizations in a vibrant rare disease network that advances clinical research, builds an interdisciplinary workforce, and strengthens clinical trial readiness to improve outcomes for individuals with sex chromosome aneuploidy (SCA).